Kim Smith-Whitley, MD

Kim Smith-Whitley, MD

Kim Smith-Whitley, MD, is Clinical Director of the Division of Hematology and Director of the Comprehensive Sickle Cell Center at Children's Hospital of Philadelphia.

Areas of Expertise: Bone marrow failure, General hematology, Sickle cell disease
Locations: Main Campus
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

Background

Dr. Smith-Whitley is Director of the Comprehensive Sickle Cell Center, Dlinical Director of the Division of Hematology, and an associate professor of Pediatrics. She holds the Elias Schwartz, MD, Endowed Chair in Hematology.

Her clinical and research focus is on sickle cell survivorship: predicting and preventing long-term, chronic, and life-threatening complications of the disease. She initiated two innovative programs at CHOP:

  • A short-stay Hematology Acute Care Unit
  • The Blue Tie Tag program to recruit blood donors for pediatric transfusions

She received the 2010 Blockley-Osler Award for excellence in teaching clinical medicine at the bedside.

Education and Training

Medical School

MD - George Washington University School of Medicine, Washington, DC

Residency

Children's National Medical Center, Washington, DC

Fellowship

The Children's Hospital of Philadelphia, Philadelphia, PA

Board Certification

American Board of Pediatrics
American Board of Pediatrics/Hematology-Oncology

Graduate Degree

Master of Clinical Epidemiology and Biostatistics - University of Pennsylvania, Philadelphia, PA

Titles and Academic Titles

Director, Comprehensive Sickle Cell Center

Clinical Director, Division of Hematology

Attending Physician

Elias Schwartz, MD, Endowed Chair in Hematology

Associate Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

Conditions Treated

Departments and Services

Publications

Papers

2017

Antiel RM, Halpem SD, Stevens EM, Vrecenak JD, Patterson CA, Tchume-Johnson T, Smith-Whitley K, Peranteau WH, Flake AW, Baraket LP. Acceptability of In Utero Hematopoietic Cell Transplantation for Sickle Cell Disease. Med Decis Making. 2017 May 1:272989X17707214. Doi: 10.1177/0272989x17707214. [Epub ahead of print].

2015

Bride KL, Vincent T, Smith-Whitley K, Lambert MP, Bleesing JJ, Seif AE, Manno CS, Casper J, Grupp SA, Teachey DT. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. Blood. 2016 Jan 7;127(1):17-28.